Literature DB >> 21701504

E-cadherin, a new mixer in the Yamanaka cocktail.

William E Lowry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21701504      PMCID： PMC3128958          DOI： 10.1038/embor.2011.117

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  9 in total

Review 1.  Sticky business: orchestrating cellular signals at adherens junctions.

Authors:  Mirna Perez-Moreno; Colin Jamora; Elaine Fuchs
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

2.  Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.

Authors:  Payman Samavarchi-Tehrani; Azadeh Golipour; Laurent David; Hoon-Ki Sung; Tobias A Beyer; Alessandro Datti; Knut Woltjen; Andras Nagy; Jeffrey L Wrana
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

3.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Authors:  Ronghui Li; Jialiang Liang; Su Ni; Ting Zhou; Xiaobing Qing; Huapeng Li; Wenzhi He; Jiekai Chen; Feng Li; Qiang Zhuang; Baoming Qin; Jianyong Xu; Wen Li; Jiayin Yang; Yi Gan; Dajiang Qin; Shipeng Feng; Hong Song; Dongshan Yang; Biliang Zhang; Lingwen Zeng; Liangxue Lai; Miguel Angel Esteban; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

Review 4.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

Authors:  Hervé Acloque; Meghan S Adams; Katherine Fishwick; Marianne Bronner-Fraser; M Angela Nieto
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

5.  Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Authors:  Matthias Stadtfeld; Nimet Maherali; David T Breault; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-02-14       Impact factor: 24.633

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells.

Authors:  Yu-Fen Chou; Hsu-Hsin Chen; Maureen Eijpe; Akiko Yabuuchi; Joshua G Chenoweth; Paul Tesar; Jun Lu; Ronald D G McKay; Niels Geijsen
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

8.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

9.  Role of the murine reprogramming factors in the induction of pluripotency.

Authors:  Rupa Sridharan; Jason Tchieu; Mike J Mason; Robin Yachechko; Edward Kuoy; Steve Horvath; Qing Zhou; Kathrin Plath
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582
  9 in total
  7 in total

1.  Stemness as a cell default state.

Authors:  Jordi Casanova
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

2.  Epithelial self-healing is recapitulated by a 3D biomimetic E-cadherin junction.

Authors:  Daniel J Cohen; Martijn Gloerich; W James Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

3.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.

Authors:  Toni Celià-Terrassa; Oscar Meca-Cortés; Francesca Mateo; Alexia Martínez de Paz; Nuria Rubio; Anna Arnal-Estapé; Brian J Ell; Raquel Bermudo; Alba Díaz; Marta Guerra-Rebollo; Juan José Lozano; Conchi Estarás; Catalina Ulloa; Daniel Álvarez-Simón; Jordi Milà; Ramón Vilella; Rosanna Paciucci; Marian Martínez-Balbás; Antonio García de Herreros; Roger R Gomis; Yibin Kang; Jerónimo Blanco; Pedro L Fernández; Timothy M Thomson
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

4.  Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).

Authors:  Cristina Oliveras-Ferraros; Bruna Corominas-Faja; Sílvia Cufí; Alejandro Vazquez-Martin; Begoña Martin-Castillo; Juan Manuel Iglesias; Eugeni López-Bonet; Ángel G Martin; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-09-19       Impact factor: 4.534

5.  Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Authors:  Begoña Martin-Castillo; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Silvia Cufí; José Manuel Moreno; Bruna Corominas-Faja; Ander Urruticoechea; Ángel G Martín; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.

Authors:  Bruna Corominas-Faja; Sílvia Cufí; Cristina Oliveras-Ferraros; Elisabet Cuyàs; Eugeni López-Bonet; Ruth Lupu; Tomás Alarcón; Luciano Vellon; Juan Manuel Iglesias; Olatz Leis; Ángel G Martín; Alejandro Vazquez-Martin; Javier A Menendez
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

7.  TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition.

Authors:  Yuan Wang; Shuang Chen; Qingyuan Jiang; Jie Deng; Fuyi Cheng; Yi Lin; Lin Cheng; Yixin Ye; Xiaolei Chen; Yunqi Yao; Xiaomei Zhang; Gang Shi; Lei Dai; Xiaolan Su; Yong Peng; Hongxin Deng
Journal:  Cell Death Dis       Date:  2020-06-25       Impact factor: 8.469
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.